US2390529A
(en)
|
1942-02-03 |
1945-12-11 |
Ernst A H Friedheim |
Hydrazino-1,3,5-triazino derivatives of substituted phenylarsenic compounds
|
BE516129A
(hu)
|
1949-07-23 |
|
|
|
GB935538A
(en)
|
1959-04-06 |
1963-08-28 |
Stop Motion Devices Corp |
Stop-motion head for use on knitting machines
|
GB1274436A
(en)
|
1970-06-09 |
1972-05-17 |
Wolfen Filmfab Veb |
Process for the sensitization of photographic silver chloride and silver chlorobromide emulsions that may contain colour couplers
|
BE754242A
(fr)
|
1970-07-15 |
1971-02-01 |
Geigy Ag J R |
Diamino-s-triazines et dinitro-s-triazines
|
US3867383A
(en)
|
1971-03-29 |
1975-02-18 |
Ciba Geigy Corp |
Monoanthranilatoanilino-s-triazines
|
CH606334A5
(hu)
|
1974-06-21 |
1978-10-31 |
Ciba Geigy Ag |
|
US3998828A
(en)
|
1975-01-31 |
1976-12-21 |
Pfizer Inc. |
4-[2-(1,3-Dialkyl-1,2,3,4-tetra-hydropyrimidine-2,4-dione-5-carboxamido)ethyl]-1-piperidine sulfonamide
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
DE2948434A1
(de)
|
1979-12-01 |
1981-06-11 |
Hoechst Ag, 6000 Frankfurt |
1-piperidinsulfonylharnstoffe und verfahren zu ihrer herstellung
|
JPS58186682A
(ja)
|
1982-04-27 |
1983-10-31 |
日本化薬株式会社 |
セルロ−ス又はセルロ−ス含有繊維材料の染色法
|
US4474599A
(en)
|
1982-07-14 |
1984-10-02 |
The Dow Chemical Company |
1-(Pyridyl)-1H-1,2,3-triazole derivatives, and use as herbicidal agents
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
GB8325370D0
(en)
|
1983-09-22 |
1983-10-26 |
Fujisawa Pharmaceutical Co |
Benzoxazoline and benzothiazoline derivatives
|
US4593102A
(en)
|
1984-04-10 |
1986-06-03 |
A. H. Robins Company, Inc. |
N-[(amino)alkyl]-1-pyrrolidine, 1-piperidine and 1-homopiperidinecarboxamides (and thiocarboxamides) with sulfur linked substitution in the 2, 3 or 4-position
|
IT1196195B
(it)
|
1984-07-20 |
1988-11-10 |
Minnesota Mining & Mfg |
Copulanti formatori di colorante cian ed elementi e procedimenti fotografici
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
JPS61129129A
(ja)
|
1984-11-28 |
1986-06-17 |
Kureha Chem Ind Co Ltd |
抗腫瘍剤
|
FI855180A
(fi)
|
1985-01-18 |
1986-07-19 |
Nissan Chemical Ind Ltd |
Pyrazolsulfonamidderivat, foerfarande foer dess framstaellande och det innehaollande ograesgift.
|
DE3512630A1
(de)
|
1985-04-06 |
1986-10-23 |
Hoechst Ag, 6230 Frankfurt |
Verfahren zum faerben oder bedrucken von cellulosefasern oder cellulosemischfasern
|
EP0246749A3
(en)
|
1986-05-17 |
1988-08-31 |
AgrEvo UK Limited |
Triazole herbicides
|
JPS6339875A
(ja)
|
1986-08-05 |
1988-02-20 |
Nissin Food Prod Co Ltd |
ピリミジン誘導体
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
US4775762A
(en)
|
1987-05-11 |
1988-10-04 |
The Dow Chemical Company |
Novel (1H-1,2,3-triazol-1-yl)pyridines
|
US5962490A
(en)
|
1987-09-25 |
1999-10-05 |
Texas Biotechnology Corporation |
Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
|
DE3813885A1
(de)
|
1988-04-20 |
1989-11-02 |
Schering Ag |
1-chlorpyrimidinyl-1h-1,2,4-triazol-3-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider, fungizider und pflanzenwachstumsregulierender wirkung
|
DE3813886A1
(de)
|
1988-04-20 |
1989-11-02 |
Schering Ag |
1-triazinyl-1h-1,2,4-triazol-3- sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider, fungizider und pflanzenwachstumsregulierender wirkung
|
US5220028A
(en)
|
1988-10-27 |
1993-06-15 |
Nissan Chemical Industries, Ltd. |
Halogeno-4-methylpyrazoles
|
US5041443A
(en)
|
1989-02-21 |
1991-08-20 |
Dainippon Pharmaceutical Co., Ltd. |
Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof
|
ATE107922T1
(de)
|
1989-03-03 |
1994-07-15 |
Dainippon Pharmaceutical Co |
2-(1-piperazinyl)-4-phenylcycloalkanpyridin- derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
|
MY106533A
(en)
|
1990-02-20 |
1995-06-30 |
Sumitomo Chemical Co |
A 4-tert.-butyl imidazole derivative and its production and use.
|
CA2036147A1
(en)
|
1990-06-29 |
1991-12-30 |
Hiroki Tomioka |
A 1-pyridylimidazole derivative and its production and use
|
JPH0499768A
(ja)
|
1990-08-17 |
1992-03-31 |
Dainippon Pharmaceut Co Ltd |
4―(4―フェニルピリジン―2―イル)ピペラジン―1―オキシド誘導体
|
ATE176987T1
(de)
|
1990-12-31 |
1999-03-15 |
Monsanto Co |
Verminderung der wechselwirkung zwischen pestizide auf nutzpflanzen
|
US5252590A
(en)
|
1991-06-28 |
1993-10-12 |
Sumitomo Chemical Company, Limited |
1-pyridylimidazole derivative
|
IT1252567B
(it)
|
1991-12-20 |
1995-06-19 |
Italfarmaco Spa |
Derivati di 5-isochinolinsolfonammidi inibitori delle protein-chinasi
|
AU665238B2
(en)
|
1992-02-28 |
1995-12-21 |
Zenyaku Kogyo Kabushiki Kaisha |
S-triazine derivative and remedy for estrogen-dependent diseases containing the same as active ingredient
|
JPH0625177A
(ja)
|
1992-07-09 |
1994-02-01 |
Nissan Chem Ind Ltd |
ピラゾール誘導体及び除草剤
|
JP3409165B2
(ja)
|
1993-04-28 |
2003-05-26 |
株式会社林原生物化学研究所 |
養毛剤とその製造方法
|
JP3719612B2
(ja)
|
1993-06-14 |
2005-11-24 |
塩野義製薬株式会社 |
ヘテロ環を含有する尿素誘導体
|
JP3545461B2
(ja)
|
1993-09-10 |
2004-07-21 |
エーザイ株式会社 |
二環式ヘテロ環含有スルホンアミド誘導体
|
IL115420A0
(en)
|
1994-09-26 |
1995-12-31 |
Zeneca Ltd |
Aminoheterocyclic derivatives
|
ES2303337T3
(es)
|
1995-01-20 |
2008-08-01 |
G.D. Searle Llc |
Inhibidores de la proteasa retroviral de bis-hidroxietilamino sulfonamida.
|
IL117580A0
(en)
|
1995-03-29 |
1996-07-23 |
Merck & Co Inc |
Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them
|
WO1998021191A1
(fr)
|
1995-05-16 |
1998-05-22 |
Nissan Chemical Industries, Ltd. |
Derives de cyanoethylmelamine et procede de production
|
FR2735127B1
(fr)
|
1995-06-09 |
1997-08-22 |
Pf Medicament |
Nouvelles piperazines heteroaromatiques utiles comme medicaments.
|
ES2100129B1
(es)
|
1995-10-11 |
1998-02-16 |
Medichem Sa |
Nuevos compuestos aminopiridinicos policiclicos inhibidores de acetilcolinesterasa, procedimiento para su preparacion y su utilizacion.
|
DE19541146A1
(de)
|
1995-10-25 |
1997-04-30 |
Schering Ag |
Imidazolderivate und deren Verwendung als Stickstoffmonoxid-Synthase-Inhibitoren
|
GB9602166D0
(en)
|
1996-02-02 |
1996-04-03 |
Zeneca Ltd |
Aminoheterocyclic derivatives
|
FR2744449B1
(fr)
|
1996-02-02 |
1998-04-24 |
Pf Medicament |
Nouvelles piperazines aromatiques derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
|
WO1997028128A1
(en)
|
1996-02-02 |
1997-08-07 |
Zeneca Limited |
Heterocyclic compounds useful as pharmaceutical agents
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
JPH09291034A
(ja)
|
1996-02-27 |
1997-11-11 |
Yoshitomi Pharmaceut Ind Ltd |
縮合ピリジン化合物およびその医薬としての用途
|
US6262113B1
(en)
|
1996-03-20 |
2001-07-17 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
AU722662B2
(en)
|
1996-05-20 |
2000-08-10 |
Darwin Discovery Limited |
Quinoline sulfonamides as TNF inhibitors and as PDE-IV inhibitors
|
US5843485A
(en)
|
1996-06-28 |
1998-12-01 |
Incoe Corporation |
Valve-gate bushing for gas-assisted injection molding
|
DE19629335A1
(de)
|
1996-07-20 |
1998-01-22 |
Golden Records Ass Internation |
Karte aus Kunststoff
|
US5984882A
(en)
|
1996-08-19 |
1999-11-16 |
Angiosonics Inc. |
Methods for prevention and treatment of cancer and other proliferative diseases with ultrasonic energy
|
US6020357A
(en)
|
1996-12-23 |
2000-02-01 |
Dupont Pharmaceuticals Company |
Nitrogen containing heteroaromatics as factor Xa inhibitors
|
DE19702988A1
(de)
|
1997-01-28 |
1998-07-30 |
Hoechst Ag |
Isoxazol- und Crotonsäureamidderivate und deren Verwendung als Arzneimittel und Diagnostika
|
WO1998040379A1
(en)
|
1997-03-11 |
1998-09-17 |
E.I. Du Pont De Nemours And Company |
Heteroaryl azole herbicides
|
US7863444B2
(en)
|
1997-03-19 |
2011-01-04 |
Abbott Laboratories |
4-aminopyrrolopyrimidines as kinase inhibitors
|
US6399358B1
(en)
|
1997-03-31 |
2002-06-04 |
Thomas Jefferson University |
Human gene encoding human chondroitin 6-sulfotransferase
|
JPH11158073A
(ja)
|
1997-09-26 |
1999-06-15 |
Takeda Chem Ind Ltd |
アデノシンa3拮抗剤
|
DE19743435A1
(de)
|
1997-10-01 |
1999-04-08 |
Merck Patent Gmbh |
Benzamidinderivate
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
CA2315715C
(en)
|
1997-12-22 |
2010-06-22 |
Bayer Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
US6106849A
(en)
|
1998-01-21 |
2000-08-22 |
Dragoco Gerberding & Co. Ag |
Water soluble dry foam personal care product
|
US6214879B1
(en)
|
1998-03-24 |
2001-04-10 |
Virginia Commonwealth University |
Allosteric inhibitors of pyruvate kinase
|
GB9811427D0
(en)
|
1998-05-29 |
1998-07-22 |
Zeneca Ltd |
Chemical compounds
|
AU754204B2
(en)
|
1998-09-01 |
2002-11-07 |
Bristol-Myers Squibb Company |
Potassium channel inhibitors and method
|
DE19841985A1
(de)
|
1998-09-03 |
2000-03-09 |
Schering Ag |
Dialkylsulfonsäure- und Dialkylcarbonsäure-Derivate
|
DE69928414T2
(de)
|
1998-09-18 |
2006-08-03 |
Abbott Gmbh & Co. Kg |
4-aminopyrrolopyrimidine als kinaseinhibitoren
|
UY25842A1
(es)
|
1998-12-16 |
2001-04-30 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
US6211182B1
(en)
|
1999-03-08 |
2001-04-03 |
Schering Corporation |
Imidazole compounds substituted with a six or seven membered heterocyclic ring containing two nitrogen atoms
|
US6274620B1
(en)
|
1999-06-07 |
2001-08-14 |
Biochem Pharma Inc. |
Thiophene integrin inhibitors
|
US6492408B1
(en)
|
1999-07-21 |
2002-12-10 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Small molecules useful in the treatment of inflammatory disease
|
CA2382789A1
(en)
|
1999-08-27 |
2001-03-08 |
Sugen, Inc. |
Phosphate mimics and methods of treatment using phosphatase inhibitors
|
JP2003509412A
(ja)
|
1999-09-17 |
2003-03-11 |
シーオーアール セラピューティクス インコーポレイテッド |
Xa因子阻害剤
|
MX226123B
(es)
|
1999-09-17 |
2005-02-07 |
Millennium Pharm Inc |
Benzamidas e inhibidores del factor xa relacionadas.
|
DE60115394T2
(de)
|
2000-02-29 |
2006-10-19 |
Millennium Pharmaceuticals, Inc., Cambridge |
Benzamide und ähnliche inhibitoren vom faktor xa
|
US20010037689A1
(en)
|
2000-03-08 |
2001-11-08 |
Krouth Terrance F. |
Hydraulic actuator piston measurement apparatus and method
|
MXPA03000458A
(es)
|
2000-07-20 |
2004-06-02 |
Neurogen Corp |
Ligandos receptores de capsaicina.
|
FR2817349B1
(fr)
|
2000-11-28 |
2003-06-20 |
Centre Nat Rech Scient |
Nouveau procede de criblage de modulateurs de la transcription bacterienne
|
JP2002193710A
(ja)
|
2000-12-25 |
2002-07-10 |
Kumiai Chem Ind Co Ltd |
ピリミジン又はトリアジン誘導体及び農園芸用殺菌剤
|
US6525091B2
(en)
|
2001-03-07 |
2003-02-25 |
Telik, Inc. |
Substituted diarylureas as stimulators for Fas-mediated apoptosis
|
DE10112926B4
(de)
|
2001-03-13 |
2005-11-10 |
Schebo Biotech Ag |
Verwendung von Aminooxyacetat zur Tumorbehandlung
|
AU2002256418A1
(en)
|
2001-04-27 |
2002-11-11 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of bace
|
WO2002089793A1
(en)
|
2001-05-07 |
2002-11-14 |
Smithkline Beecham Corporation |
Sulfonamides
|
EP1990422A1
(en)
|
2001-05-23 |
2008-11-12 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pyruvate-kinase as a novel target molecule
|
US6967212B2
(en)
|
2001-05-30 |
2005-11-22 |
Bristol-Myers Squibb Company |
Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
|
YU98003A
(sh)
|
2001-06-11 |
2006-03-03 |
Biovitrum Ab. |
Supstituisana sulfonamidna jedinjenja, postupak za njihovu upotrebu kao leka za tretiranje poremećaja cns, gojaznosti i dijabetesa tipa ii
|
JP4083397B2
(ja)
|
2001-06-18 |
2008-04-30 |
株式会社ルネサステクノロジ |
半導体集積回路装置
|
WO2002102313A2
(en)
|
2001-06-19 |
2002-12-27 |
Bristol-Myers Squibb Company |
Pyrimidine inhibitors of phosphodiesterase (pde) 7
|
BR0212189A
(pt)
|
2001-08-15 |
2004-07-13 |
Du Pont |
Composto, método para controle de pragas invertebradas e composição para controle de pragas invertebradas
|
WO2003016289A1
(en)
|
2001-08-17 |
2003-02-27 |
Ciba Specialty Chemicals Holding Inc. |
Triazine derivatives and their use as sunscreens
|
JP4753336B2
(ja)
|
2001-09-04 |
2011-08-24 |
日本化薬株式会社 |
新規アリル化合物及びその製法
|
JP2003081937A
(ja)
|
2001-09-07 |
2003-03-19 |
Bayer Ag |
ベンゼンスルホンアミド誘導体
|
WO2003037252A2
(en)
|
2001-10-30 |
2003-05-08 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
US6878196B2
(en)
|
2002-01-15 |
2005-04-12 |
Fuji Photo Film Co., Ltd. |
Ink, ink jet recording method and azo compound
|
US7148236B2
(en)
|
2002-01-17 |
2006-12-12 |
Merck & Co., Inc. |
Modulators of acetylcholine receptors
|
US20040180889A1
(en)
|
2002-03-01 |
2004-09-16 |
Pintex Pharmaceuticals, Inc. |
Pin1-modulating compounds and methods of use thereof
|
JP4725946B2
(ja)
|
2002-03-13 |
2011-07-13 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ヒストンデアセチラーゼの新規な阻害剤としてのスルホニル誘導体
|
ATE521592T1
(de)
|
2002-03-13 |
2011-09-15 |
Janssen Pharmaceutica Nv |
Histone-deacetylase-inhibitoren
|
JP4901102B2
(ja)
|
2002-05-03 |
2012-03-21 |
エクセリクシス, インク. |
プロテインキナーゼモジュレーターおよびその使用方法
|
GB0215775D0
(en)
|
2002-07-06 |
2002-08-14 |
Astex Technology Ltd |
Pharmaceutical compounds
|
US20040067234A1
(en)
|
2002-07-11 |
2004-04-08 |
Paz Einat |
Isocitrate dehydrogenase and uses thereof
|
EP1546121B1
(en)
|
2002-07-18 |
2012-08-29 |
Janssen Pharmaceutica NV |
Substituted triazine kinase inhibitors
|
EP1534695B1
(en)
|
2002-08-09 |
2010-09-29 |
Merck Sharp & Dohme Corp. |
Tyrosine kinase inhibitors
|
JP2004107220A
(ja)
|
2002-09-13 |
2004-04-08 |
Mitsubishi Pharma Corp |
TNF−α産生抑制剤
|
KR20050059294A
(ko)
|
2002-10-24 |
2005-06-17 |
스테릭스 리미티드 |
11-베타-하이드록시 스테로이드 데하이드로게나제 형태 1및 형태 2의 억제제
|
AR042052A1
(es)
|
2002-11-15 |
2005-06-08 |
Vertex Pharma |
Diaminotriazoles utiles como inhibidores de proteinquinasas
|
EP1575580A4
(en)
|
2002-12-02 |
2009-06-10 |
Arqule Inc |
METHODS OF TREATING CANCERS
|
US7282568B2
(en)
|
2002-12-16 |
2007-10-16 |
Medarex, Inc. |
Human monoclonal antibodies against interleukin 8 (IL-8)
|
JP2006515883A
(ja)
|
2003-01-10 |
2006-06-08 |
スレッシュオールド ファーマシューティカルズ, インコーポレイテッド |
2−デオキシグルコースによる癌の処置
|
US7358262B2
(en)
|
2003-01-29 |
2008-04-15 |
Whitehead Institute For Biomedical Research |
Identification of genotype-selective anti-tumor agents
|
WO2004089470A2
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
New amide derivatives and pharmaceutical use thereof
|
WO2004073619A2
(en)
|
2003-02-14 |
2004-09-02 |
Smithkline Beecham Corporation |
Ccr8 antagonists
|
WO2004074438A2
(en)
|
2003-02-14 |
2004-09-02 |
Smithkline Beecham Corporation |
Ccr8 antagonists
|
WO2004076640A2
(en)
|
2003-02-25 |
2004-09-10 |
Ambion, Inc. |
Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same
|
WO2004110375A2
(en)
|
2003-06-06 |
2004-12-23 |
Merck & Co., Inc. |
Combination therapy for the treatment of diabetes
|
US6818631B1
(en)
|
2003-08-15 |
2004-11-16 |
Nippon Soda Co. Ltd. |
Fungicidal pyrimidine derivatives
|
WO2005035507A2
(en)
|
2003-10-10 |
2005-04-21 |
Bayer Pharmaceuticals Corporation |
4-aminopyrimidine derivatives for treatment of hyperproliferative disorders
|
US20080051414A1
(en)
|
2003-10-14 |
2008-02-28 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Protein Kinase Inhibitors
|
AU2003297904A1
(en)
|
2003-12-12 |
2005-07-14 |
University Of Maryland, Baltimore |
Immunomodulatory compounds that target and inhibit the py+3 binding site of tyrosene kinase p56 lck sh2 domain
|
JP2007517046A
(ja)
|
2003-12-24 |
2007-06-28 |
サイオス・インコーポレーテツド |
Tgf−ベータ阻害剤による悪性神経膠腫の治療
|
US20050170316A1
(en)
|
2004-01-29 |
2005-08-04 |
Russell Bruce M. |
Toothbrush for detecting the presence of plaque
|
WO2005074946A1
(en)
|
2004-02-10 |
2005-08-18 |
Adenobio N.V. |
Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases
|
CA2556589A1
(en)
|
2004-02-24 |
2005-09-01 |
Bioaxone Therapeutique Inc. |
4-substituted piperidine derivatives
|
US7588779B2
(en)
|
2004-05-28 |
2009-09-15 |
Andrx Labs, Llc |
Pharmaceutical formulation containing a biguanide and an angiotensin antagonist
|
GB0412526D0
(en)
|
2004-06-05 |
2004-07-14 |
Leuven K U Res & Dev |
Type 2 diabetes
|
US8058313B2
(en)
|
2004-06-24 |
2011-11-15 |
Temple University—Of the Commonwealth System of Higher Education |
Alpha, beta-unsaturated sulfones, sulfoxides, sulfonimides, sulfinimides, acylsulfonamides and acylsulfinamides and therapeutic uses thereof
|
TW200606152A
(en)
|
2004-07-02 |
2006-02-16 |
Tanabe Seiyaku Co |
Piperidine compound and process for preparing the same
|
FR2872704B1
(fr)
|
2004-07-12 |
2007-11-02 |
Laurent Schwartz |
Pluritherapie contre le cancer
|
EP1814551A2
(en)
|
2004-09-20 |
2007-08-08 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
|
CA2581623A1
(en)
|
2004-09-23 |
2006-03-30 |
Reddy Us Therapeutics, Inc. |
Novel pyridine compounds, process for their preparation and compositions containing them
|
JP2008514590A
(ja)
|
2004-09-24 |
2008-05-08 |
アストラゼネカ・アクチエボラーグ |
ベンゾイミダゾール誘導体、それを含む組成物、その製造方法及びその使用
|
WO2006038594A1
(ja)
|
2004-10-04 |
2006-04-13 |
Ono Pharmaceutical Co., Ltd. |
N型カルシウムチャネル阻害薬
|
EP1812008A4
(en)
|
2004-10-20 |
2008-10-29 |
Smithkline Beecham Corp |
ANTAGONISTS OF THE IL-8 RECEPTOR
|
EP1807417A2
(en)
|
2004-11-04 |
2007-07-18 |
Neurogen Corporation |
Pyrazolylmethyl heteroaryl derivatives
|
SE0402762D0
(sv)
|
2004-11-11 |
2004-11-11 |
Astrazeneca Ab |
Indazole sulphonamide derivatives
|
WO2006055880A2
(en)
|
2004-11-16 |
2006-05-26 |
Genzyme Corporation |
Diagnostic pkm2 methods and compositions
|
WO2006063294A2
(en)
|
2004-12-09 |
2006-06-15 |
Kalypsys, Inc. |
Novel inhibitors of histone deacetylase for the treatment of disease
|
US20100160324A1
(en)
|
2004-12-30 |
2010-06-24 |
Astex Therapeutics Limited |
Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
|
US20100160304A1
(en)
|
2005-01-19 |
2010-06-24 |
Dainippon Sumitomo Pharma Co., Ltd |
Aromatic sulfone compound as aldosterone receptor modulator
|
CA2594708A1
(en)
|
2005-01-25 |
2006-08-03 |
Astrazeneca Ab |
Chemical compounds
|
CA2598423C
(en)
|
2005-02-18 |
2014-05-27 |
Astrazeneca Ab |
Antibacterial piperidine derivatives
|
CA2606804A1
(en)
|
2005-05-03 |
2006-11-09 |
Ranbaxy Laboratories Limited |
Antimicrobial agents
|
EP1891028A1
(de)
|
2005-05-18 |
2008-02-27 |
Forschungsverbund Berlin e.V. |
Nicht-peptidische inhibitoren der akap-pka-wechselwirkung
|
EP2687608B1
(en)
|
2005-06-08 |
2017-02-08 |
Millennium Pharmaceuticals, Inc. |
Methods for the identification, assessment, and treatment of patients with cancer therapy
|
GB0513702D0
(en)
|
2005-07-04 |
2005-08-10 |
Sterix Ltd |
Compound
|
AR054529A1
(es)
|
2005-07-05 |
2007-06-27 |
Astrazeneca Ab |
Derivados de benzazepina como moduladores del receptor de 5-hidroxi-triptamina 6
|
WO2007008143A1
(en)
|
2005-07-08 |
2007-01-18 |
Astrazeneca Ab |
Heterocyclic sulfonamide derivatives as inhibitors of factor xa
|
AU2006283846B2
(en)
|
2005-08-26 |
2012-04-05 |
Merck Serono Sa |
Pyrazine derivatives and use as PI3K inhibitors
|
US8133900B2
(en)
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
FI20055644A0
(fi)
|
2005-12-02 |
2005-12-02 |
Nokia Corp |
Ryhmäviestintä
|
US20090048227A1
(en)
|
2005-12-22 |
2009-02-19 |
Chakravarty Pasun K |
Substituted-1-Phthalazinamines As Vr- 1 Antagonists
|
JP2009530231A
(ja)
|
2006-01-20 |
2009-08-27 |
スミスクライン ビーチャム コーポレーション |
代謝及び神経系の疾患の治療におけるスルホンアミド誘導体の使用
|
JP2007238458A
(ja)
|
2006-03-06 |
2007-09-20 |
D Western Therapeutics Institute Inc |
新規なイソキノリン誘導体及びこれを含有する医薬
|
EP1999121A1
(en)
|
2006-03-17 |
2008-12-10 |
AstraZeneca AB |
Novel tetralins as 5-ht6 modulators
|
EP2004619A1
(en)
|
2006-03-23 |
2008-12-24 |
Amgen Inc. |
1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases
|
CN101437519A
(zh)
|
2006-03-31 |
2009-05-20 |
艾博特公司 |
吲唑化合物
|
TW200815426A
(en)
|
2006-06-28 |
2008-04-01 |
Astrazeneca Ab |
New pyridine analogues II 333
|
WO2008019139A2
(en)
|
2006-08-04 |
2008-02-14 |
Beth Israel Deaconess Medical Center |
Inhibitors of pyruvate kinase and methods of treating disease
|
WO2008024284A2
(en)
|
2006-08-21 |
2008-02-28 |
Merck & Co., Inc. |
Sulfonylated piperazines as cannabinoid-1 receptor modulators
|
KR101428681B1
(ko)
|
2006-09-01 |
2014-08-11 |
오에이티 아그리오 가부시키가이샤 |
N―피리딜피페리딘 화합물, 그의 제조 방법 및 유해 생물 방제제
|
EP2074128B1
(en)
|
2006-10-16 |
2013-08-14 |
Medicis Pharmaceutical Corporation |
Therapeutic pyrazolyl thienopyridines
|
WO2008052190A2
(en)
|
2006-10-26 |
2008-05-02 |
Flynn Gary A |
Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
|
HUP0600810A3
(en)
|
2006-10-27 |
2008-09-29 |
Richter Gedeon Nyrt |
New sulfonamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
|
EP2121662A1
(en)
|
2006-12-04 |
2009-11-25 |
Neurocrine Biosciences, Inc. |
Substituted pyrimidines as adenosine receptor antagonists
|
CN105193799A
(zh)
|
2006-12-08 |
2015-12-30 |
米伦纽姆医药公司 |
使用经口因子xa抑制剂治疗血栓形成的单位剂量调配物和方法
|
CA2672893C
(en)
|
2006-12-15 |
2016-02-23 |
Abraxis Bioscience, Inc. |
Triazine derivatives and their therapeutical applications
|
US7897776B2
(en)
|
2007-04-23 |
2011-03-01 |
Salutria Pharmaceuticals Llc |
Sulfonamide containing compounds for treatment of inflammatory disorders
|
DK2152676T3
(da)
|
2007-04-30 |
2013-07-01 |
Prometic Biosciences Inc |
Triazinderivater, sammensætninger, der indeholder sådanne derivater, og fremgangsmåde til behandling af cancer og autoimmunsygdomme ved anvendelse af sådanne derivater
|
WO2008154026A1
(en)
|
2007-06-11 |
2008-12-18 |
Miikana Therapeutics, Inc. |
Substituted pyrazole compounds
|
EP2183239B1
(en)
|
2007-07-18 |
2012-08-22 |
Janssen Pharmaceutica, N.V. |
Sulfonamides as trpm8 modulators
|
BRPI0814628B1
(pt)
|
2007-07-20 |
2022-04-05 |
Nerviano Medical Sciences S.R.L. |
Derivados ativos de indazol substituídos como inibidores da quinase
|
TW200906818A
(en)
|
2007-07-31 |
2009-02-16 |
Astrazeneca Ab |
Chemical compounds
|
WO2009025781A1
(en)
|
2007-08-16 |
2009-02-26 |
Beth Israel Deaconess Medical Center |
Activators of pyruvate kinase m2 and methods of treating disease
|
US20090163508A1
(en)
|
2007-10-10 |
2009-06-25 |
Takeda Pharmaceutical Company Limited |
Amide compound
|
EP2053045A1
(en)
|
2007-10-26 |
2009-04-29 |
Syngenta Participations AG |
Novel imidazole derivatives
|
NZ584387A
(en)
|
2007-10-26 |
2011-10-28 |
Syngenta Participations Ag |
Novel imidazole derivatives
|
US8642660B2
(en)
|
2007-12-21 |
2014-02-04 |
The University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
GB0805477D0
(en)
|
2008-03-26 |
2008-04-30 |
Univ Nottingham |
Pyrimidines triazines and their use as pharmaceutical agents
|
JP5277685B2
(ja)
|
2008-03-26 |
2013-08-28 |
富士ゼロックス株式会社 |
電子写真感光体、画像形成装置、プロセスカートリッジ及び画像形成方法
|
US20090281089A1
(en)
|
2008-04-11 |
2009-11-12 |
Genentech, Inc. |
Pyridyl inhibitors of hedgehog signalling
|
CN101575408B
(zh)
|
2008-05-09 |
2013-10-30 |
Mca技术有限公司 |
用作阻燃剂和光稳定剂的聚三嗪基化合物
|
FR2932483A1
(fr)
|
2008-06-13 |
2009-12-18 |
Cytomics Systems |
Composes utiles pour le traitement des cancers.
|
WO2010007756A1
(ja)
|
2008-07-14 |
2010-01-21 |
塩野義製薬株式会社 |
Ttk阻害作用を有するピリジン誘導体
|
GB0815781D0
(en)
|
2008-08-29 |
2008-10-08 |
Xention Ltd |
Novel potassium channel blockers
|
EP2326735B1
(en)
|
2008-09-03 |
2016-11-16 |
The Johns Hopkins University |
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
|
WO2010028179A1
(en)
|
2008-09-03 |
2010-03-11 |
Dr. Reddy's Laboratories Ltd. |
Heterocyclic compounds as gata modulators
|
JP2010079130A
(ja)
|
2008-09-29 |
2010-04-08 |
Fuji Xerox Co Ltd |
電子写真感光体、プロセスカートリッジ、及び画像形成装置
|
ES2620634T3
(es)
|
2008-10-09 |
2017-06-29 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Activadores de piruvato quinasa humana
|
JP2012509321A
(ja)
|
2008-11-21 |
2012-04-19 |
ミレニアム ファーマシューティカルズ, インコーポレイテッド |
癌および他の疾患または障害の処置のための、4−[6−メトキシ−7−(3−ピペリジン−1−イル−プロポキシ)キナゾリン−4−イル]ピペラジン−1−カルボン酸(4−イソプロポキシフェニル)−アミドの乳酸塩およびその薬学的組成物
|
JP2010181540A
(ja)
|
2009-02-04 |
2010-08-19 |
Fuji Xerox Co Ltd |
電子写真感光体、プロセスカートリッジ、及び画像形成装置
|
PL2394999T3
(pl)
|
2009-02-06 |
2014-06-30 |
Nippon Shinyaku Co Ltd |
Pochodna aminopirazyny i lek
|
CN108524505A
(zh)
|
2009-03-13 |
2018-09-14 |
安吉奥斯医药品有限公司 |
用于细胞增殖相关病症的方法和组合物
|
AU2010234526B2
(en)
|
2009-04-06 |
2016-07-21 |
Agios Pharmaceuticals, Inc. |
Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use
|
PL2427441T3
(pl)
|
2009-05-04 |
2017-06-30 |
Agios Pharmaceuticals, Inc. |
Aktywatory PKM2 do stosowania w leczeniu raka
|
WO2010130638A1
(en)
|
2009-05-14 |
2010-11-18 |
Evotec Ag |
Sulfonamide compounds, pharmaceutical compositions and uses thereof
|
US20120238576A1
(en)
|
2009-06-08 |
2012-09-20 |
California Capital Equity, Llc |
Triazine Derivatives and their Therapeutical Applications
|
EP2440054A4
(en)
|
2009-06-09 |
2012-12-12 |
California Capital Equity Llc |
PYRIDILTRIA INHIBITOR OF HEDGEHOG SIGNALING
|
WO2010144522A1
(en)
|
2009-06-09 |
2010-12-16 |
Abraxis Bioscience, Llc |
Ureidophenyl substituted triazine derivatives and their therapeutical applications
|
ES2618630T3
(es)
|
2009-06-29 |
2017-06-21 |
Agios Pharmaceuticals, Inc. |
Composiciones terapéuticas y métodos de uso relacionados
|
MX2012000256A
(es)
|
2009-06-29 |
2012-04-19 |
Agios Pharmaceuticals Inc |
Compuestos terapeuticos y composiciones.
|
US20120189670A1
(en)
|
2009-09-14 |
2012-07-26 |
Kirkpatrick D Lynn |
Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
|
JP5473851B2
(ja)
|
2009-09-30 |
2014-04-16 |
富士フイルム株式会社 |
高分子フィルム、位相差フィルム、偏光板及び液晶表示装置
|
US8652534B2
(en)
|
2009-10-14 |
2014-02-18 |
Berry Pharmaceuticals, LLC |
Compositions and methods for treatment of mammalian skin
|
WO2011050210A1
(en)
|
2009-10-21 |
2011-04-28 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
US9062076B2
(en)
|
2009-10-22 |
2015-06-23 |
Fibrotech Therapeutics Pty Ltd |
Fused ring analogues of anti-fibrotic agents
|
ES2642109T3
(es)
|
2009-12-09 |
2017-11-15 |
Agios Pharmaceuticals, Inc. |
Compuestos terapéuticamente activos para su uso en el tratamiento de cáncer caracterizados por tener una mutación de IDH
|
MX2012010011A
(es)
|
2010-03-01 |
2012-10-05 |
Myrexis Inc |
Compuestos y usos terapeuticos de los mismos.
|
AU2011245441B2
(en)
|
2010-04-29 |
2014-12-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Activators of human pyruvate kinase
|
WO2011143160A2
(en)
|
2010-05-10 |
2011-11-17 |
The Johns Hopkins University |
Metabolic inhibitor against tumors having an idh mutation
|
EP2575815A4
(en)
|
2010-06-04 |
2013-12-25 |
Albany Molecular Res Inc |
GLYCIN TRANSPORTER 1 INHIBITORS, METHODS OF MAKING THE SAME, AND USES THEREOF
|
JP6081354B2
(ja)
|
2010-07-16 |
2017-02-15 |
アジオス ファーマシューティカルズ, インコーポレイテッド |
治療活性組成物およびそれらの使用方法
|
CA2849432A1
(en)
|
2010-10-20 |
2012-04-26 |
Yota Devices Ipr Ltd |
Mobile device
|
RU2598606C3
(ru)
|
2010-10-21 |
2021-12-20 |
МЕДИВЭЙШН ТЕКНОЛОДЖИЗ ЭлЭлСи |
Кристаллическая тозилатная соль (8s,9r)-5-фтор-8-(4-фторфенил)-9-(1-метил-1н-1,2,4-триазол-5-ил)-8-9-дигидро-2н-пиридо[4,3,2-de]фталазин-3(7н)-она
|
FR2967674B1
(fr)
|
2010-11-23 |
2012-12-14 |
Pf Medicament |
Derives d'heteroarylsulfonamides, leur preparation et leur application en therapeutique humaine
|
JP5907986B2
(ja)
|
2010-11-29 |
2016-04-26 |
ガリオン ファーマシューティカルズ インコーポレイテッド |
呼吸制御障害または呼吸制御疾患の処置用の呼吸刺激薬としての化合物
|
TWI549947B
(zh)
|
2010-12-29 |
2016-09-21 |
阿吉歐斯製藥公司 |
治療化合物及組成物
|
WO2012105391A1
(en)
|
2011-02-04 |
2012-08-09 |
Nec Corporation |
Radio communication system, base station apparatus, radio resource control method, and non-transitory computer readable medium
|
LT3406251T
(lt)
|
2011-05-03 |
2024-02-12 |
Agios Pharmaceuticals, Inc. |
Piruvatkinazės aktyvatoriai, skirti panaudoti terapijai
|
JP6267112B2
(ja)
*
|
2011-05-03 |
2018-01-24 |
アジオス ファーマシューティカルズ, インコーポレイテッド |
ピルビン酸キナーゼアクチベーターの使用方法
|
TW201636330A
(zh)
|
2011-05-24 |
2016-10-16 |
拜耳知識產權公司 |
含有硫醯亞胺基團之4-芳基-n-苯基-1,3,5-三氮雜苯-2-胺
|
CN102827170A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
US20140249150A1
(en)
|
2011-10-13 |
2014-09-04 |
Agios Pharmaceuticals, Inc |
Activators of pyruvate kinase m2 and methods of treating disease
|
CN102659765B
(zh)
|
2011-12-31 |
2014-09-10 |
沈阳药科大学 |
嘧啶及三嗪类化合物的制备方法和应用
|
UA117451C2
(uk)
|
2012-01-06 |
2018-08-10 |
Аджиос Фармасьютікалз, Інк. |
Терапевтично активні сполуки і способи їх застосування
|
JP6228130B2
(ja)
|
2012-01-19 |
2017-11-08 |
アジオス ファーマシューティカルズ, インコーポレイテッド |
治療活性化合物およびそれらの使用方法
|
US9474779B2
(en)
|
2012-01-19 |
2016-10-25 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compositions and their methods of use
|
EP2634259A1
(en)
|
2012-03-01 |
2013-09-04 |
Deutsches Krebsforschungszentrum |
Means and methods for the determination of (D)-2-hydroxyglutarate (D2HG)
|
US20150011751A1
(en)
|
2012-03-09 |
2015-01-08 |
Carna Biosciences, Inc. |
Novel triazine derivative
|
WO2014015422A1
(en)
|
2012-07-27 |
2014-01-30 |
Ontario Institute For Cancer Research |
Cellulose-based nanoparticles for drug delivery
|
US9579324B2
(en)
|
2013-07-11 |
2017-02-28 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
US20150031627A1
(en)
|
2013-07-25 |
2015-01-29 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|